Check the EU HTAR Course in Open Classroom – Available in 9 Languages!

HTA4Patients hero 1600x370

HTA4Patients

Bringing Health Technology Assessment closer to Patients

  • New course available

    Learn how the EU Regulation coming in 2025 will affect HTA processes and how you can get involved.

  • Train with us

    Interested in an online training session on EU HTAR? Click the link to pre-register!

     

  • Learn all about HTA

    Follow all our Health Technology Assessment courses. Content is continually updated throughout the HTA4Patients project.

HTAR in a Nutshell

Are you curious to learn more about the EU Health Technology Assessment Regulation (HTAR)?

In this video, we’ll cover the key changes introduced by the HTAR regulation, its objectives and purposes, and what it means for Health Technology Assessments (HTAs) in the EU.

We’ll also explore the stakeholders involved, their primary roles, and how patients and patient organizations can engage and contribute to this important process.

sustainability workshop group photo

Consolidation & Sustainability Alignment Workshop in Brussels

website 4

EUPATI at the 5th Annual Stakeholder Network in Brussels

website 5

EUPATI HTA Ambassadors Workshop in Rome

website 6

EU HTAR Training at WECAN Academy Face-to-Face Event in Rome

website 7

''HTAR Under the Microscope: Making Patient Involvement Work'' Session at PEOF, co-led by EUPATI and EPF

website 9

''Patient Involvement in HTA Processes - Focus On Training and Capacity Building'' Session at the 9th Patients as Partners Europe conference, co-led by EUPATI, Parkinson’s Europe and Roche

website 10

EUPATI at the First Cancer Mission Fair in Warsaw

What is HTA?

According to Health Technology Assessment International (HTAi.org) Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine the value of a health technology at different points in its lifecycle. The purpose is to inform decision-making in order to promote an equitable, efficient and high-quality health system. 

 

About HTA4Patients Project

The European Patients Academy on Therapeutic Innovation (EUPATI) is leading a 3-year training project entitled ‘HTA4Patients’ from 01 March 2023.    

The European Union’s new framework for Health Technology Assessment (HTA) regulation (EU 2021/2282) represents a unique opportunity to strengthen the involvement of patient communities in HTA processes. Strong and informed input from patients and patient representation is necessary to support this new framework and efficient HTA.

HTA4Patients will enhance the education, training and information that EUPATI already provides on HTA via its Open Classroom and Toolbox empowering patients and patient organisations to play a vital role in the implementation of the new framework.    

For more information about the HTA4Patients project, please contact the EUPATI Project Coordinator for HTA4Patients at [email protected]

  • Objective 1

    Creating an e-learning training course on the new HTA Regulation and what it means for patients

     

  • Objective 2

    Updating EUPATI’s existing patient training content on HTA aligning with the new EU regulation 

  • Objective 3

    Developing interactive online training sessions (in 5 languages). Preparing participants taking part in joint clinical assessments and joint scientific consultations with national HTA bodies 

  • Objective 4

    Implementing sustainability measures to ensure continuity of the project outputs in the future 

Our work plan

WorkPackages 1-4

  • WP 1

    • Project Management
    • Coordination
    • Infrastructure
  • WP 2

    • E-learning training course

  • WP 3

    • Online training sessions
  • WP 4

    • Communication
    • Dissemination
    • Outreach and Sustainability

Project Governance

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

More information